TELA Bio (TELA) EPS (Basic) Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 16.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 54.76% |
| Jun 30, 2025 | 56.86% |
| Mar 31, 2025 | -8.70% |
| Dec 31, 2024 | 67.92% |
| Sep 30, 2024 | 6.67% |
| Jun 30, 2024 | -10.87% |
| Mar 31, 2024 | 63.49% |
| Dec 31, 2023 | -10.42% |
| Sep 30, 2023 | 29.69% |
| Jun 30, 2023 | 47.73% |
| Mar 31, 2023 | 16.00% |
| Dec 31, 2022 | 18.64% |
| Sep 30, 2022 | -12.28% |
| Jun 30, 2022 | -54.39% |
| Mar 31, 2022 | -33.93% |
| Dec 31, 2021 | -9.26% |
| Sep 30, 2021 | -7.55% |
| Jun 30, 2021 | -7.55% |
| Mar 31, 2021 | 11.11% |
| Dec 31, 2020 | -100.91% |
| Sep 30, 2020 | 97.65% |
| Jun 30, 2020 | 98.04% |
| Mar 31, 2020 | 97.67% |
| Dec 31, 2019 | 287.70% |
| Sep 30, 2019 | -42.55% |